Results 231 to 240 of about 10,020,739 (382)

Pancreatic cancer: Three connecticut families in which an adult child presented with the disease before a parent

, 1978
M. Huyett Sangree
openalex   +1 more source

Next-Generation Sequencing: An Advanced Diagnostic Tool for Detection of Pancreatic Disease/Disorder. [PDF]

JGH Open
Biswas S, Afrose S, Mita MA, Hasan MR, Shimu MSS, Zaman S, Saleh MA.   +6 more
europepmc   +1 more source

The somatostatin-secreting pancreatic δ-cell in health and disease

Nature Reviews Endocrinology, 2018
P. Rorsman, M. Huising
semanticscholar   +1 more source

Engineered Plasmonic and Fluorescent Nanomaterials for Biosensing, Motion, Imaging, and Therapeutic Applications

Advanced Materials, EarlyView.
A schematic illustration of how noble metals can be used to create nanoparticles (NPs) or nanoclusters (NCs). Noble metal NPs, due to their plasmonic properties, enable photothermal therapy and surface‐enhanced Raman scattering (SERS). In contrast, NCs, which lack a plasmonic resonance band, exhibit fluorescence, making them ideal for bioimaging ...
David Esporrín‐Ubieto, Juan C. Fraire, Daniel Sánchez‐deAlcázar, Samuel Sánchez   +3 more
wiley   +1 more source

Role of peroxisome proliferator-activated receptor α in disease of pancreatic β cells [PDF]

, 1998
Yan-Ting Zhou, Michio Shimabukuro, May-Yun Wang, Young Lee, Moritake Higa, Joseph L. Milburn, Christopher B. Newgard, Roger H. Unger   +7 more
openalex   +1 more source

Mitochondrial uncoupling protein 2: a central player in pancreatic disease pathophysiology. [PDF]

Mol Med
Wang K, Zhang L, Deng B, Zhao K, Chen C, Wang W.   +5 more
europepmc   +1 more source

Cytokeratin-positive cells in the bone marrow from patients with pancreatic, periampullary malignancy and benign pancreatic disease show no prognostic information. [PDF]

BMC Cancer, 2020
Hugenschmidt H, Labori KJ, Brunborg C, Verbeke CS, Seeberg LT, Bendigtsen Schirmer C, Renolen A, Borgen E, Naume B, Wiedswang G.   +9 more
europepmc   +1 more source

MUTE‐Seq: An Ultrasensitive Method for Detecting Low‐Frequency Mutations in cfDNA With Engineered Advanced‐Fidelity FnCas9

Advanced Materials, EarlyView.
An advanced‐fidelity CRISPR nuclease, FnCas9‐AF2, is rationally engineered to discriminate single‐base mismatches with unprecedented level precision. Integrated into the MUTE‐Seq workflow, FnCas9‐AF2 depletes wild‐type cell‐free DNA, thereby exposing rare tumor‐derived mutant DNA (a molecular “needle in a haystack”).
Sunghyeok Ye, Jin‐Soo Kim, Myungshin Kim, Ki‐Yeon Kim, Yoon‐Ho Won, Taegun Park, Sungjae An, Haerin Jeong, Hee‐Joon Chung, In Seon Lee, Myoung‐Hee Kang, Chan Young Kang, Mi Young Kim, Jae Ho Chung, Jeong‐An Gim, Woochang Hwang, Yonggoo Kim, Song Cheol Kim, Sungho Lee, Junho K Hur, Junseok W Hur   +20 more
wiley   +1 more source

Total Parenteral Nutrition in Pancreatic Disease

, 1984
John P. Grant, Susan Elizabeth James, Virginia M. Grabowski, Katherine M. Trexler   +3 more
openalex   +2 more sources

Antibodies against p53 protein in serum of patients with benign or malignant pancreatic and biliary diseases. [PDF]

, 1995
Pierre Laurent‐Puig, Richard Lubin, Sylvie Semhoun-Ducloux, G Pelletier, Catherine Fourré, Michel Ducreux, M.J. Briantais, C Buffet, Thierry Soussi   +8 more
openalex   +1 more source